Chugai Pharmaceutical
¥6,032.00Change from previous close: −2.32%Absolute change: −¥143.00
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- ¥9.93T
- Enterprise value
- ¥8.96T
- P/E (trailing 12 months)
- 21.1
- Forward P/E
- 25.6
- PEG
- 1.57
- Price/book
- 4.89
- Price/sales
- 7.39
- EV/EBITDA
- 13.2
- EV/revenue
- 6.67
Profitability and growth
- Gross margin
- 71.3%
- Operating margin
- 47.1%
- Net margin
- 35.1%
- ROE
- 23.5%
- ROA
- 17.1%
- Revenue growth (year over year)
- 17.8%
- Earnings growth (year over year)
- 19.7%
Financial health
- Total cash
- ¥962.57B
- Total debt
- ¥0
- Current ratio
- 4.35
- Quick ratio
- 3.43
Dividends
- Annual dividend per share
- ¥132.00
- Dividend yield
- 2.2%
- Payout ratio
- 48.2%
- Ex-dividend date
- December 29, 2026
Analysts and estimates
- Average price target
- ¥8,870.00
- Median price target
- ¥8,900.00
- High price target
- ¥13,300.00
- Low price target
- ¥6,100.00
- Analysts with a price target
- 15
- Consensus
- Buy
- Forward EPS
- ¥235.91
- EPS estimate, current year
- ¥306.49
Shares and trading
- Beta
- 0.55
- Average volume
- 2.8M
- Shares outstanding
- 1.65B
- Float
- 639.38M
- Institutional ownership
- 19.8%
- Insider ownership
- 59.9%